- Evaluation of CD45 antigen expression in patients with multiple myeloma and its effect on time to progression or relapse2014 | Faculty of Medicine in Pilsen
- The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine
- The Inclusion of a Gemcitabine + Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Human epidermal growth factor receptor 2-positive breast cancer relapsing post-adjuvant trastuzumab: pattern of recurrence, treatment and outcome2011 | Third Faculty of Medicine
- Tissue microRNAs as predictive markers for gastric cancer patients undergoing palliative chemotherapy2016 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- The Inclusion of a Gemcitabine Nab-paclitaxel Regimen as a 2nd Line Treatment for Advanced Pancreatic Cancer - First Experience2017 | First Faculty of Medicine, Faculty of Physical Education and Sport
- MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab2015 | Publication without faculty affiliation
- Association of ABC gene profiles with time to progression and resistance in ovarian cancer revealed by bioinformatics analyses2019 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Long-term outcome of Simpson IV meningioma resection: Would it improve with adjuvant SRS?2021 | First Faculty of Medicine
- Subgroup analysis in RAISE: a randomized, double-blind phase III study of irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) plus ramucirumab or placebo in patients with metastatic colorectal carcinoma progression(aEuro)2016 | Publication without faculty affiliation
- Complex karyotype and translocation t(4;14) define patients with high-risk newly diagnosed multiple myeloma: results of CMG2002 trial +12012 | First Faculty of Medicine
- An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma2013 | Third Faculty of Medicine
- Multicentered patient-based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapse2016 | First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study2022 | First Faculty of Medicine